Longeveron (LGVN) Competitors $0.89 -0.03 (-3.69%) As of 10:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LGVN vs. VNRX, ALTS, HYPD, INCR, GANX, OSTX, ANL, ELYM, INKT, and MNOVShould you be buying Longeveron stock or one of its competitors? The main competitors of Longeveron include VolitionRx (VNRX), ALT5 Sigma (ALTS), Hyperion DeFi (HYPD), InterCure (INCR), Gain Therapeutics (GANX), OS Therapies (OSTX), Adlai Nortye (ANL), Eliem Therapeutics (ELYM), MiNK Therapeutics (INKT), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry. Longeveron vs. Its Competitors VolitionRx ALT5 Sigma Hyperion DeFi InterCure Gain Therapeutics OS Therapies Adlai Nortye Eliem Therapeutics MiNK Therapeutics MediciNova VolitionRx (NYSE:VNRX) and Longeveron (NASDAQ:LGVN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk. Do analysts rate VNRX or LGVN? VolitionRx currently has a consensus price target of $3.50, indicating a potential upside of 463.61%. Longeveron has a consensus price target of $7.67, indicating a potential upside of 758.53%. Given Longeveron's higher probable upside, analysts clearly believe Longeveron is more favorable than VolitionRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VolitionRx 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Longeveron 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is VNRX or LGVN more profitable? Longeveron has a net margin of -894.40% compared to VolitionRx's net margin of -2,321.14%. VolitionRx's return on equity of 0.00% beat Longeveron's return on equity.Company Net Margins Return on Equity Return on Assets VolitionRx-2,321.14% N/A -163.39% Longeveron -894.40%-95.91%-79.69% Does the media refer more to VNRX or LGVN? In the previous week, Longeveron had 1 more articles in the media than VolitionRx. MarketBeat recorded 2 mentions for Longeveron and 1 mentions for VolitionRx. VolitionRx's average media sentiment score of 0.58 beat Longeveron's score of 0.00 indicating that VolitionRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment VolitionRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Longeveron 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation and earnings, VNRX or LGVN? Longeveron has higher revenue and earnings than VolitionRx. VolitionRx is trading at a lower price-to-earnings ratio than Longeveron, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVolitionRx$1.32M50.65-$35.32M-$0.25-2.48Longeveron$2.39M7.87-$15.97M-$6.28-0.14 Do insiders and institutionals believe in VNRX or LGVN? 8.1% of VolitionRx shares are owned by institutional investors. Comparatively, 10.0% of Longeveron shares are owned by institutional investors. 10.4% of VolitionRx shares are owned by company insiders. Comparatively, 11.2% of Longeveron shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, VNRX or LGVN? VolitionRx has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Longeveron has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. SummaryLongeveron beats VolitionRx on 10 of the 17 factors compared between the two stocks. Get Longeveron News Delivered to You Automatically Sign up to receive the latest news and ratings for LGVN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LGVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGVN vs. The Competition Export to ExcelMetricLongeveronMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.81M$3.38B$6.13B$10.61BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-0.1421.9385.8627.54Price / Sales7.87274.32540.53202.58Price / CashN/A47.1237.9261.55Price / Book0.6110.2012.986.78Net Income-$15.97M-$52.40M$3.30B$275.79M7 Day Performance16.70%6.22%4.73%2.99%1 Month Performance8.90%15.91%9.96%9.50%1 Year Performance-51.47%31.98%84.61%35.97% Longeveron Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGVNLongeveron2.1162 of 5 stars$0.89-3.7%$7.67+758.5%-49.6%$18.81M$2.39M-0.1420Analyst ForecastVNRXVolitionRx2.3195 of 5 stars$0.62+3.0%$3.50+461.8%-16.1%$67.03M$1.32M-1.7380ALTSALT5 Sigma0.1087 of 5 stars$2.82-9.0%N/A+65.1%$66.99M$12.53M0.00170News CoverageAnalyst ForecastShort Interest ↑HYPDHyperion DeFi0.688 of 5 stars$10.24+7.0%$2.00-80.5%-74.9%$66.60M$60K-0.1840Analyst ForecastGap DownINCRInterCure1.1832 of 5 stars$1.56+6.8%N/A-10.6%$66.53M$238.85M0.00350News CoverageAnalyst ForecastGap UpHigh Trading VolumeGANXGain Therapeutics3.0445 of 5 stars$1.81+1.1%$8.00+342.0%+4.5%$64.35M$50K-2.8720News CoverageAnalyst ForecastOptions VolumeOSTXOS TherapiesN/A$2.01-2.0%$18.00+795.5%N/A$63.61MN/A-2.54N/AGap DownANLAdlai Nortye1.8885 of 5 stars$1.77+2.9%$9.00+408.5%-10.7%$63.47M$5M0.00127News CoverageAnalyst ForecastAnalyst RevisionELYMEliem TherapeuticsN/A$2.13+1.4%N/A-64.9%$63.37MN/A-4.029INKTMiNK Therapeutics2.587 of 5 stars$13.70-1.9%$37.50+173.7%+115.2%$63.14MN/A-4.7630News CoverageAnalyst ForecastMNOVMediciNova3.077 of 5 stars$1.25-1.6%$7.00+460.0%-37.4%$62.29M$134.60K-5.0010 Related Companies and Tools Related Companies VNRX Alternatives ALTS Alternatives HYPD Alternatives INCR Alternatives GANX Alternatives OSTX Alternatives ANL Alternatives ELYM Alternatives INKT Alternatives MNOV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LGVN) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longeveron Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longeveron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
